timothy sykes logo

Watchlists-Penny Stock Investment Strategy

The #1 Biotech Stock Right Now 🧪📈

Timothy SykesAvatar
Written by Timothy Sykes
Reviewed by Jack Kellogg Fact-checked by Ellis Hobbs
Updated 11/7/2024 6 min read

Welcome traders,

I made another classic trade yesterday using the same patterns as always.

It’s like clockwork in this market!

Every day I wake up and look for big-percent gainers. Then I scan the price action for key areas of support that match my trade patterns.

Here’s how it went yesterday, I took a 9% profit:

Source: Profit.ly

This biotech stock is a huge former-runner.

The history of spiking was a hint that the price could push higher after I bought shares. In total, the price spiked 75% on Thursday, November 7.

I’m perfectly happy with a 9% profit … I’m not trying to catch the whole move. Nobody knows when these spikes will reverse direction.

The goal is to take the meat of the move when the chart matches our popular patterns.

Today, I’ll show my exact position on this volatile biotech stock.

Burn this pattern into your brain! We’ll likely see another opportunity this week.

Volatile Biotech Spike

© Millionaire Media, LLC

Biotech stocks are HOT right now.

The spikes aren’t reliable over a long term, but we can trade the intraday volatility for profits.

The biotech sector is overwhelmingly volatile right now partly due to the 3,000%* spike from Bright Minds Biosciences Inc. (NASDAQ: DRUG) in mid October.

These follow-up biotech spikes are a result of the immense moves from other stocks in the sector (DRUG).

Short sellers keep trying to ride this momentum lower. And it sounds like a good strategy, these biotech spikes are unsustainable.

But … If there are too many short sellers in the stock, any bullish momentum could squeeze some of them. And that causes a domino effect of short sellers blowing up. As a result, the stock skyrockets.

It’s especially common on low-float biotech stocks, because there’s a limited number of shares.

Anything below 10 million shares is considered a low float.

StocksToTrade shows that DRUG has a float of 4.4 million shares.

And the biotech stock that I traded yesterday, Ensysce Biosciences Inc. (NASDAQ: ENSC), has a float of 8.3 million shares.

The low float explains the immense volatility we’ve seen on ENSC since October 22. And it lends itself to volatility in the future!

Take a look at the multi-day chart of ENSC below, this is a 380%* spike! Every candle represents 10 minutes:

ENSC chart multi-month, 10-minute candles Source: StocksToTrade

Notice that the price is still up …

There will be more opportunities to trade this stock.

Let’s take a look at my position from November 7 so that you know what to look for.

My ENSC Trade

© Millionaire Media, LLC

My millionaire students and I trade with the same patterns over and over again.

They’re based on human psychology. See, people are predictable during times of high stress. Like when they have cash in a volatile stock.

Their stress manifests in the form of popular patterns.

My millionaire students learned these patterns after studying tons of trades. Every spike is a little different, and traders need enough experience to recognize the patterns in real time.

But my newest students can follow the AI trading-bot instead …

Ever since AI exploded on the scene in early 2023, I knew it had the potential to help my students learn this process.

So … Over several months, I fed the AI trade after trade. And eventually, it caught on!

>> Prompt my AI trading-bot with the ENSC ticker <<

It will spit out a trade plan as if you asked me directly!

One of my favorite patterns right now, and a pattern the AI might suggest, is dip-buying shares after a big spike.

For example, on November 7, I watched ENSC spike in the morning, but I didn’t buy shares until it fell lower and started to show signs of consolidation.

That level of consolidation was my risk level. That’s where I would sell if the trade fell apart.

But, because I only focus on the best plays, these stocks often follow my trade plans. I track all my trades on Profit.ly, where it currently shows that I have a 76% win rate.

Again, here’s what made ENSC the best play of the day:

ENSC was one of the hottest spikers on Thursday morning with a history of spiking. It’s a biotech stock. It has a low float. And it started to follow my trade pattern.

Here’s what my trade looks like overlaid on the chart, every candle represents one trading minute:

ENSC chart intraday, 1-minute candles Source: StocksToTrade

Keep ENSC on your watchlist this month!

The stock will show us more volatility in the future.

Here are some things to watch:

  • The Nasdaq extended ENSC’s form 10-Q filing deadline to November 14.
  • It also received a deadline extension for the minimum bid-price requirement until December 19.

This is a sketchy stock, lol. It can barely stay listed!

That’s why short sellers are targeting it …

Get ready for more squeezes!

Cheers.

 

*Past performance does not indicate future results


How much has this post helped you?



Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”